BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Drug Development

  Good News for Ocugen: COVID Vaccine Hold Lifted, New Clinical Trial Announced

  The FDA lifts its clinical hold on Ocugen’s COVID-19 vaccine, and Ocugen announces a clinical trial for the treatment of inherited retinal diseases.

  February 28, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  Talent Acquisition vs Recruitment: What’s the Difference?

  Understanding the difference between talent acquisition and recruitment is vital not only for your hiring process but for the entire organization.

  February 28, 2022

   · 

  5 min read

   · 

  Brandi Marcene
• 

  Deals

  Prioritize Programs and Preserve Resources to Weather 2022 Market Volatility

  That’s the advice for emerging growth life sciences companies in 2022, according to attorney Frank Rahmani, partner in the global life science and capital markets practice group at Sidley Austin LLP.

  February 28, 2022

   · 

  5 min read

   · 

  Gail Dutton
• 

  Drug Development

  A Platform for Hope in the Face of Rare and Uncommon Diseases

  Acrotech is looking to launch drugs with either improved efficacy and/or safety over currently available treatments in the oncology, dermatology, neuroscience and rare disease spaces.

  February 28, 2022

   · 

  4 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Amryt’s Rare Skin Disease (Epidermolysis Bullosa) Treatment Rejected by FDA

  The FDA declined approval for Amryt Pharma’s therapeutic oleogel-S10. The topical gel is intended to treat a group of rare skin diseases called epidermolysis bullosa.

  February 28, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Business

  DNA Damage Response Consortium Aims to Rapidly Develop Brain Cancer Therapies

  The National Brain Tumor Society is investing over $1 million in the DNA damage response consortium’s start. Here’s how this consortium will help researchers.

  February 28, 2022

   · 

  5 min read

   · 

  Abbey Glasure
• Emerging Demand of High-Flow Nasal Cannula Market – Advancements in Healthcare Device Manufacturing

  The demand within the global high flow nasal cannula market is predicted to rise alongside advancements in healthcare device manufacturing.

  February 28, 2022

   · 

  5 min read
• Handicap Assistive Robots Market: Robotic wheelchairs are likely to hold major share of the global market

  Handicap assistive robots, also known as disability robots, are designed to help people who have physical disabilities that impede their daily tasks.

  February 28, 2022

   · 

  6 min read
• Glioblastoma Market: Key Drivers & Regional Analysis

  Glioblastoma also known as glioblastoma multiforme is one of the most aggressive and most lethal brain disease that is currently taking many lives.

  February 28, 2022

   · 

  5 min read
• Growth of the Global Disposable Tweezers Market – New Development and Key Trends (2029)

  Disposable tweezers refer to small-sized tools that are mainly utilized for plucking objects during cosmetic procedures, surgical procedures, and dental procedures.

  February 28, 2022

   · 

  5 min read